Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-003284

CHIEF FINANCIAL OFFICER gave up 1,047 shares (to pay taxes)

  • CHIEF FINANCIAL OFFICER acquired 3,019 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2022-03-21 Option exercise +3,019 6,695 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2022-03-21 Shares withheld for taxes −1,047 $10.98 $11,496 5,648 D
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2022-03-21 Option exercise · Restricted Share Unit −3,019 0 D
Loading xslF345X03/form4-03232022_040315.xml…